CM Management’s Immunogen Inc IMGN Stock Holding History

CM Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-500,000	Closed	-$14.8M	–	79
2023 Q4	$14.8M	Hold	500,000	–	–	11.91%	1
2023 Q3	$7.93M	Hold	500,000	–	–	8.42%	1
2023 Q2	$9.44M	Hold	500,000	–	–	9.2%	1
2023 Q1	$1.92M	Hold	500,000	–	–	2.28%	13
2022 Q4	$2.48M	Hold	500,000	–	–	2.96%	11
2022 Q3	$2.39M	Buy	500,000 +25,000	+5%	+$132K	2.67%	11
2022 Q2	$2.14M	Buy	475,000 +25,000	+6%	+$109K	2.28%	12
2022 Q1	$2.14M	Buy	450,000 +75,000	+20%	+$415K	1.8%	19
2021 Q4	$2.78M	Hold	375,000	–	–	2.1%	10
2021 Q3	$2.13M	Hold	375,000	–	–	1.59%	15
2021 Q2	$2.47M	Hold	375,000	–	–	1.79%	14
2021 Q1	$3.04M	Hold	375,000	–	–	2.26%	11
2020 Q4	$2.42M	Buy	+375,000	New	+$2.19M	2.24%	13

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

CM Management's IMGN Position: Q1 2024 in Review

CM Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 500,000 shares — an estimated $14.8M sold.

CM Management first reported a position in IMGN in Q4 2020 and held it in 13 quarters. The position peaked at $14.8M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

CM Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
CM Management sold 500,000 Immunogen Inc shares in Q1 2024, an estimated $14.8M.
CM Management first reported a position in Immunogen Inc in Q4 2020 and held it in 13 quarters.
CM Management's Immunogen Inc position peaked at $14.8M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on CM Management's 13F filing for Q1 2024, filed 14 May 2024.